NASDAQ : CUPR
Cuprina Holdings (Cayman) Limited — Key statistics
Healthcare · Medical Instruments & Supplies · Singapore
Last price 1.84 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 12.89M |
| Enterprise Value | 13.05M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 24, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 5.24M |
| Shares Outstanding | 7.00M |
| Shares Change (YoY) | +13.73% |
| Shares Change (QoQ) | +10.21% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.91% |
| Float | 5.24M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 321.38 |
| Forward PS | n/a |
| PB Ratio | 1.21 |
| P/TBV Ratio | 3.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 325.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.35 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -328.04 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -1,569.06% |
| Return on Assets (ROA) | -58.90% |
| Return on Invested Capital (ROIC) | -61.07% |
| Return on Capital Employed (ROCE) | -89.62% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $3,879 |
| Profits Per Employee | -$363,345 |
| Employee Count | 10 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -76.87% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 3.01 |
| Relative Strength Index (RSI) | 42.04 |
| Average Volume (20 Days) | 111,356 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 14,383 |
| Short Previous Month | 3,141 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 0.08 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 38,791 |
| Gross Profit | -501 |
| Operating Income | -3.76M |
| Pretax Income | -3.63M |
| Net Income | -3.63M |
| EBITDA | -3.73M |
| EBIT | -3.76M |
| Loss Per Share | -$1.42 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.49M |
| Total Debt | 2.65M |
| Net Cash | -162,434 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 3.93M |
| Book Value Per Share | 1.47 |
| Working Capital | 3.28M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.14M |
| Capital Expenditures | -45,523 |
| Depreciation & Amortization | 28,553 |
| Net Borrowing | -2.15M |
| Free Cash Flow | -7.19M |
| FCF Per Share | -$1.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | -1.29% |
| Operating Margin | -9,680.15% |
| Pretax Margin | -9,366.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.73% |
| Shareholder Yield | -13.73% |
| Earnings Yield | -77.17% |
| FCF Yield | -57.64% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 27, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 13.2 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |